Afatinib Dimaleate |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
Albendazole |
Tablet (Chewable) |
II (Paddle) |
50 |
0.1 N HCl |
900 |
10, 15, 20, 30 and 45 |
2016/03/17 |
Albendazole |
Tablet |
|
|
Refer to USP |
|
|
2013/08/15 |
Albuterol Sulfate |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
Albuterol Sulfate |
Tablet (Extended Release) |
II (Paddle) |
50 |
0.1 N HCl |
900 |
1, 2, 4, 6, 9 and 12 hours |
2007/04/09 |
Alectinib HCl |
Capsule |
II (Paddle) with sinker |
100 |
pH 1.2, Simulated Gastric Fluid without pepsin, containing 4 % Triton X-100 [polyoxyethylene[10]octylphenyl ether] |
900 |
10, 20, 30, 45, 60, 75 and 90 |
2016/03/17 |
Alendronate Sodium |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
Alendronate Sodium/Cholecalciferol |
Tablet |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
Alfuzosin HCl |
Tablet (Extended Release) |
II (Paddle) |
100 |
0.01 N HCl |
900 |
1, 2, 12, 20 hours |
2007/06/18 |
Aliskiren Hemifumarate |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
Aliskiren Hemifumarate |
Capsule (pellet) |
I (Basket) |
100 |
0.01 M HCl (degas) |
500 |
5, 10, 15, 20, 30 and 45 |
2018/02/08 |
Aliskiren Hemifumarate/Amlodipine Besylate |
Tablet |
I (Basket) |
100 |
0.01 N HCl, pH 2.0 |
500 |
10, 15, 20, 30 and 45 |
2012/06/07 |
Aliskiren Hemifumarate/Amlodipine Besylate/Hydrochlorothiazide |
Tablet |
I (Basket) |
100 |
0.01 N HCl |
900 |
10, 15, 20, 30 and 45 |
2012/06/07 |
Aliskiren Hemifumarate/Hydrochlorothiazide |
Tablet |
I (Basket) |
100 |
0.1 N HCl |
900 |
10, 15, 20, 30 and 45 |
2009/10/08 |
Aliskiren Hemifumarate/Valsartan |
Tablet |
I (Basket) |
100 |
Phosphate Buffer, pH 6.8 |
1000 |
5, 10, 15, 20, 30 and 45 |
2010/12/23 |
Allopurinol |
Suspension |
II (Paddle) |
75 |
0.01 N HCl |
900 |
10, 20, 30, 40, 50 and 60 |
2024/11/01 |
Allopurinol |
Tablet |
|
|
Refer to USP |
|
|
2007/07/25 |
Almotriptan Malate |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
Alogliptin Benzoate |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
Alogliptin Benzoate/ Metformin HCl |
Tablet |
II (Paddle) |
50 |
0.01 N HCl |
900 |
5, 10, 15, 20 and 30 |
2015/11/19 |